Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemiaPaul K.J.D. de Jonge, Harry Dolstra, P.M.M. van Hauten et al.|Cancer Immunology Immunotherapy|2023Cited by 18